Insurezone, Inc. – Trademark Portfolio
Entity Type: 03
Insurezone, Inc. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 9 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include INSUREHOPE, INSUREZONE, AGENTSECURE, and AGENT SECURE. The owner is based in Ft. Worth, TX.
550 Bailey Ave., Suite 150
Ft. Worth, TX 76107
Showing of trademarks Trademarks
Trademark Classifications
Insurezone, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Insurezone, Inc. have?
Insurezone, Inc. has 10 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned, 5 cancelled.
What trademark classes does Insurezone, Inc. file in?
Insurezone, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 38 (Telecommunications). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are Insurezone, Inc.'s most well-known trademarks?
Insurezone, Inc.'s registered trademark portfolio includes well-known marks such as INSUREHOPE, INSUREZONE, AGENTSECURE, and AGENT SECURE. These are among 4 currently registered trademarks in the portfolio.
What is Insurezone, Inc.'s trademark registration success rate?
Insurezone, Inc. has a 40% trademark registration rate, with 4 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.